NOTE: If you are experiencing problems downloading a form from our page, try using an alternate browser (e.g., Firefox, Chrome, IE).
NEW!!! INSTRUCTIONS FOR SUBMITTING PROTOCOLS TO email@example.com MAILBOX
Effective April 11, 2016, all new protocol submissions, modifications, adverse events, violations and continuation reviews may be submitted by e-mail.
To submit by e-mail, all IRB forms and study documents should be submitted as one PDF that is readable, searchable, and contains standardized bookmarks.
See step-by-step instructions on how to prepare your Initial Full application submission: [PDF]
Should you need to submit a response to requested revisions, see these step-by-step instructions: [PDF]
Only have Adobe Reader? To perform OCR and bookmark, download Adobe Pro.
Email completed PDF submissions to firstname.lastname@example.org. You will receive an automated notification of receipt by email. Please contact Heather Gozzard at Heather.Gozzard@uky.edu or Michelle Hill at Michelle.Hill@uky.edu with any questions.
There are seven sections to the IRB application. Depending on the nature of your research, some sections will apply to your research, some will not. Please review each section to determine applicability to your research, and include the Forms appropriate for your study in your IRB application submission. When preparing your application, sort applicable materials alphabetically (e.g., each packet has applicable forms A-Z). Incomplete or inappropriately compiled applications are subject to being sent back to the PI.
Note: The Sections include a combination of Forms to fill out, and guidance/ instruction for documents you may need to provide duplicates of or that you may need to develop. Forms to fill out (when applicable to your research) are denoted by the option to download either a WORD or RTF document.
Note: The icon indicates a document that is a PDF E-form.
Core Application - completion of A & B is required
|Form B||Research Description with Appendices [WORD] [RTF] Revised 10/12/15||The WORD or RTF version may be saved to the location of your choice, and then used as a guideline while editing for your specific protocol.|
Informed Consent/Assent Process
You must select at a minimum, applicable item(s) from Form C - F.
Form C Instructions [HTML]
*Mandatory if in HIPAA Covered Entity
HIPAA Authorization Regulations [PDF]
Form D Instructions [HTML]
Form E Instructions [HTML]
Form F Instructions [HTML]
|Form G||NIH Informed Consent Form: MEDICAL IRB ONLY||Form G Instructions [HTML]|
|Form H||For recruitment of Non-English speaking subjects, attach translated consent document||
Form H Instructions & info pertaining to subjects from a foreign culture [HTML]
HIPAA (Health Insurance Portability and Accountability Act)
Visit ORI's Health Insurance Portability and Accountability Act (HIPAA) web page to determine if your research falls under the HIPAA Privacy Regulation.
Complete Form I if you plan to de-identify the data, however, if you retain a link the HIPAA Waiver of Authorization (Form K) applies.
Effective 12/5/13, this form has been eliminated. If HIPAA Authorization is required for your research, you must use the Informed Consent/HIPAA Combined Template as a guide to develop your consent/authorization document.
Waiver of Authorization Guidance [HTML]
Additional Study Materials
Complete/attach all of the below items that apply to your research.
Proposed advertisement(s) of any type for recruiting subjects
Form L Instructions [HTML]
|Form M||Proposed data collection instrument(s) (i.e., survey(s), questionnaire(s))||Form M Instructions [HTML]|
|Form N||Effective 8/28/13, this form has been eliminated. Applicable off-site questions have been incorporated into other parts of the IRB application. Please be sure to complete the most recent versions of Form A and Form B for your application submission.||
Off-Site Research - IRB Application Instructions [HTML]
|Form O||Investigational New Drug Form: MEDICAL IRB ONLY|
|Form P||Investigational New Device Form: MEDICAL IRB ONLY|
|Form Q||Radioactive Materials: MEDICAL IRB ONLY|
|Form S||package insert or FDA approved label: MEDICAL IRB ONLY|
Complete all of the forms below that apply to your research.
Adults with Impaired Consent Capacity: Web-Based Tool [to determine research risk level and likelihood of consent impairment]
Form T Instructions [HTML]
Form U Instructions [HTML]
Form V Instructions & Suggested Consent Form Language [HTML]
Form W Instructions [HTML]
Materials for Primary Reviewer and Detailed Protocol/Grant Application Review
|Form X Form Y||Note "Form X" and "Form Y" for Disclosure of Financial Interest (DFI) have been replaced by a question in "Form A" and the Office of Sponsored Projects Administration (OSPA) online financial disclosure form.||
Instructions for OSPA's online financial disclosure form [PDF]
OSPA's Disclosure of Financial Interest Survey Sample [PDF]
Signature Assurance Sheet [PDF] Revised 2/9/16
Form Z Instructions [HTML]
2 copies if seeking a grant or a grant received.
Sponsor's detailed drug protocol: MEDICAL IRB ONLY
Investigator Brochure: MEDICAL IRB ONLY
|Form DD||Device proposal: MEDICAL IRB ONLY|
Other Required Committee/Review Approvals
Institutional Biosafety Committee (IBC): MEDICAL IRB ONLY
Radioactive Drug Research Committee (RDRC): MEDICAL IRB ONLY
Markey Cancer Center (MCC) Protocol Review Committee (PRC): MEDICAL IRB ONLY
[previously for GCRC but no longer in use]
|Form II||Medical Center/College of Medicine: MEDICAL IRB ONLY|
Please note that the Nonmedical IRB meets twice per month. Investigators are encouraged to submit protocols as far in advance of a deadline date as possible. In an effort to decrease the number of pages, the investigator is encouraged to submit two-sided copies whenever possible.
Full reviews require that the Principal Investigator attend the meeting at which the application is reviewed. A review date will be assigned to the protocol at the time of submission. If the PI is not available on this date, this should be made clear to staff of the Office of Research Integrity at the time of submission.
Note that all incomplete IRB applications will not be scheduled for review but returned to the PI.
If you have questions concerning submission of a research protocol for IRB review, please call the Office of Research Integrity at 859-323-2446.